About
Claes Gustafsson is a mitochondrial biology researcher and biotech entrepreneur focused on mitochondrial gene expression and medical biochemistry. He is a co-founder of Pretzel Therapeutics, where company materials describe him as Professor of Medical Biochemistry at the University of Gothenburg, and he is also identified by Lab Manager and Inc. as co-founder and chief commercial officer of ATUM. His public profile is strongest as a scientific and commercial ecosystem builder in biotech rather than as an investor or fund manager.
Areas of interest
biotechmitochondrial biologymitochondrial gene expressionmedical biochemistrysynthetic biologybiologics manufacturingdrug developmentgenome engineering